Related Experiment Videos
Rheumatic fever diagnosis, management, and secondary prevention: a New Zealand guideline
Polly Atatoa-Carr1, Diana Lennon, Nigel Wilson
1Waikato District Health Board, Hamilton.
Insights
This summary outlines the New Zealand Guideline for Rheumatic Fever Diagnosis, Management, and Secondary Prevention. It aims to improve consistent care and reduce rheumatic fever and rheumatic heart disease impact.
Area of Science:
- Cardiology
- Public Health
- Infectious Diseases
Background:
- Rheumatic fever and rheumatic heart disease pose significant health challenges.
- Existing guidelines require adaptation for the New Zealand context.
Purpose of the Study:
- To present a summary of the New Zealand Guideline for Rheumatic Fever Diagnosis, Management, and Secondary Prevention.
- To highlight the evidence-based approach adopted for the guideline.
Main Methods:
- Development by a multidisciplinary expert writing group.
- Literature review and adaptation of the Australian guideline.
- Peer review and stakeholder consultation process.
Main Results:
- The guideline was developed and endorsed by key New Zealand health organizations.
- It has been adapted for the New Zealand context, considering local needs.
- Further guidelines on sore throat management and primary prevention are in development.
Conclusions:
- Implementation of the guideline is expected to enhance consistency in rheumatic fever management.
- The guideline aims to reduce mortality and morbidity associated with acute rheumatic fever and rheumatic heart disease.
Aim:
The National Heart Foundation of New Zealand, and the Cardiac Society of Australia and New Zealand (CSANZ) recently launched an evidence-based review and guideline entitled New Zealand Guideline for Rheumatic Fever Diagnosis, Management, and Secondary Prevention. This paper is a brief summary.
Method:
This Guideline was developed by a writing group comprising experts in the area. Relevant literature was identified and reviewed, and the Australian guideline for rheumatic fever and rheumatic heart disease was reviewed and adapted for the New Zealand context. A peer review and stakeholder consultation process followed the development of the draft document.
Results:
The final draft of the New Zealand guideline was endorsed by Te Hotu Manawa Maori, Pacific Islands Heart Beat, The Paediatric Society of New Zealand, and the Rheumatic Fever Trust of New Zealand--plus approved by a number of organisations including the Royal Australasian College of Physicians, the Australasian Society for Infectious Disease, the Pasifika Medical Association, and Te Ohu Rata o Aotearoa. Two subsequent New Zealand guidelines for rheumatic fever: Sore Throat Management and Primary Prevention are also in production. The complete guideline, and associated summary algorithms, can be downloaded from www.nhf.org.nz
Conclusion:
A New Zealand Guideline for Rheumatic Fever Diagnosis, Management and Secondary Prevention of Acute Rheumatic Fever should result in improved consistency in the approach to this disease, and reduced mortality and morbidity from acute rheumatic fever and rheumatic heart disease.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease I: Introduction
Myocarditis III: Medical Management